Maca Root: Libido, Energy & Sexual Function — A Research-Backed Guide

What is maca root?

Maca (Lepidium meyenii Walp., family Brassicaceae) is a biennial plant grown at 3,500–4,500 meters elevation in the Junin plateau of the Peruvian Andes — one of the harshest agricultural environments on Earth. The hypocotyl (the swollen root that is harvested) is a staple food for Andean populations and has been consumed continuously since at least 1600 BCE based on archaeological evidence.

Maca roots vary in color — cream/yellow, red, and black — all from the same species. Each color has a slightly different glucosinolate profile, but human clinical trials rarely specify which color was used, making comparative claims about color largely speculative.

As a Brassicaceae member, maca is botanically related to broccoli, cabbage, and mustard — which explains its glucosinolate content and mild goitrogenic potential. Unlike true adaptogens such as ashwagandha or rhodiola, maca does not measurably modulate the HPA (hypothalamic-pituitary-adrenal) axis at typical supplement doses.

Key bioactives: glucosinolates and macamides

Maca's biological activity comes from several compound classes:

• Glucosinolates (benzylglucosinolate and p-methoxybenzylglucosinolate): Hydrolyzed by gut bacteria to isothiocyanates and nitriles, which modulate steroid-hormone-metabolizing enzymes in the liver. This is the mechanism most likely responsible for maca's libido effects — not phytoestrogenic or androgenic direct action.
• Macamides (N-benzyl fatty acid amides): Unique to maca; structurally similar to anandamide (an endocannabinoid). They inhibit fatty acid amide hydrolase (FAAH) in vitro, potentially raising endocannabinoid tone — a plausible mechanism for mood and libido effects.
• Macaridine: A maca-specific alkaloid; pharmacological target unclear.
• Minerals and nutrients: Maca is genuinely nutrient-dense — high in calcium, potassium, iron, and vitamin C. In populations with food insecurity, this nutritional contribution may be meaningful independent of any adaptogen effect.

Importantly, no compound in maca has been shown to bind or agonize androgen or estrogen receptors directly, which distinguishes it from phytoestrogenic herbs like red clover or anabolic-precursor herbs making testosterone claims.

Evidence-based benefits of maca root

1. Libido and sexual desire

This is maca's most replicated clinical finding. Gonzales et al. (2002, Andrologia) — a double-blind, placebo-controlled RCT in 57 healthy men — found that 1.5 g or 3 g/day of maca for 12 weeks significantly increased self-reported sexual desire compared to placebo, with no change in testosterone, LH, FSH, estradiol, or prolactin. A follow-up by the same group (2009) replicated the libido finding in men with mild erectile dysfunction. A 2010 Cochrane-style systematic review by Brown et al. identified four qualifying RCTs and concluded maca showed a small but consistent effect on subjective sexual desire, acknowledging that sample sizes were uniformly small.

2. Antidepressant-induced sexual dysfunction (AISD)

A 2008 randomized crossover pilot (Dording et al., CNS Neuroscience & Therapeutics) in 20 outpatients on SSRIs or SNRIs found that 3 g/day of maca extract for 12 weeks significantly improved sexual dysfunction scores (Arizona Sexual Experiences Scale) versus placebo, with no interaction with antidepressant efficacy. A 2015 repeat by the same group (n=45) confirmed the effect on libido and orgasm domains. This is currently the most clinically actionable use case — AISD is common, undertreated, and a major driver of antidepressant discontinuation.

3. Menopausal symptoms

A small RCT (Meissner et al., 2006; n=14 postmenopausal women) found that 2 g/day of pre-gelatinized maca reduced Kupperman Menopausal Index scores (a composite of hot flashes, night sweats, mood, and libido) over 4 months. A 2008 trial by the same group in perimenopausal women (n=20) found reduced psychological symptoms. Both trials are small and funded by a maca producer; independent replication is needed. Estrogen and progesterone levels did not change, suggesting the mechanism is not phytoestrogenic.

4. Energy and mood (modest)

A 2009 cycling performance study (Stone et al., Journal of Ethnopharmacology) found that 14 days of maca supplementation modestly improved 40 km cycling time-trial performance compared to baseline in a small crossover design (n=8), with a trend toward improved sexual desire. Effect size was small and the trial lacked an active placebo arm. Maca's reported "energy" effects may reflect improved mood and motivation (via endocannabinoid mechanisms) rather than direct mitochondrial or ergogenic effects.

What maca does NOT do

Marketing around maca is prone to exaggeration. The evidence clearly does not support:

• Testosterone elevation: Three RCTs by Gonzales and colleagues specifically measured hormone panels and found no change in testosterone, LH, or FSH. The libido effect is real but is not mediated by testosterone.
• Muscle mass or strength gains: No RCT evidence. The cycling study showed modest performance improvement but not hypertrophy.
• Fertility in humans: Animal studies (mostly rats) show improved sperm count and motility with black maca. Human data are preliminary and not from high-quality RCTs. Do not rely on maca as a fertility treatment.
• Menstrual cycle regulation as a drug-level effect: Observational claims exist but no controlled human evidence.

Supplement forms compared

How much maca root should you take?

RCT evidence clusters around two doses:

• 1.5 g/day: The lower dose used in Gonzales (2002); effective for libido in healthy men.
• 3 g/day: The higher dose used across most AISD trials and menopausal symptom studies; generally used for more significant sexual dysfunction.

Practical guidance: start with 1.5 g/day with a meal (gelatinized form preferred). Increase to 3 g/day after 4 weeks if response is partial. Allow 6–12 weeks for meaningful assessment — effects appear to build gradually. Split the dose into two servings (morning and midday) to reduce any GI discomfort.

There is no established Tolerable Upper Intake Level. Traditional Andean consumption is estimated at 10–30 g of fresh root daily (equivalent to several grams of dried powder), suggesting substantial safety margin at typical supplement doses.

Safety and side effects

Maca has an excellent safety record at doses used in clinical trials and traditional consumption. Reported adverse effects are minor:

• GI bloating, flatulence, or loose stools (primarily with raw powder; reduced with gelatinized form)
• Headache in a minority of users during initial weeks
• Mild insomnia if taken late in the day (energy-elevating effect in some individuals)

Thyroid / goitrogen caution

Maca's glucosinolates can be hydrolyzed to thiocyanates, which competitively inhibit thyroid iodine uptake — the same mechanism responsible for the goitrogenic effect of raw cruciferous vegetables. At 1.5–3 g/day of gelatinized maca, the thiocyanate load is very low and unlikely to matter for people with normal thyroid function who consume adequate iodine. However, people with hypothyroidism, Hashimoto's thyroiditis, or iodine deficiency should discuss maca use with their physician or endocrinologist before starting, particularly if taking levothyroxine.

Hormone-sensitive conditions

Although maca does not appear to be directly estrogenic or androgenic, some researchers theorize that glucosinolate metabolites could modulate steroid-metabolizing cytochrome P450 enzymes. As a precaution, people with current or prior hormone-sensitive cancers (breast, ovarian, uterine, prostate) should consult their oncologist before using maca supplementation long term.

Drug and condition interactions

• Thyroid medications (levothyroxine): Theoretical reduction in thyroid iodine uptake from glucosinolates; take maca at a different time of day and monitor TSH if used regularly. Low-risk at typical doses in iodine-replete individuals.
• Antidepressants (SSRIs/SNRIs): Maca appears beneficial in AISD without impairing antidepressant efficacy, but this interaction should be disclosed to the prescribing clinician.
• Hormone replacement therapy / oral contraceptives: Theoretical interaction via steroid-metabolizing enzyme modulation. No case reports of clinical significance; disclose use to prescriber.
• Anticoagulants: No known interaction at typical doses.

Check our free interaction checker for additional combinations.

Who might benefit — and who should be cautious

Frequently asked questions

Related ingredients and articles